Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q3 2024 · 10-Q
Revenue$2.70M$2.70M−21.5% vs Q3 2023 Net Income-$162.15K-$162.15KN/M vs Q3 2023 EPS Diluted-$0.02-$0.02N/M vs Q3 2023 Operating Income-$156,608N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$184,438−21.2% Margins · derivedOperating margin-5.8%−23.0 pt vs Q3 2023
Net margin-6.0%−23.1 pt vs Q3 2023
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end